Growth Metrics

Clorox (CLX) Gains from Investment Securities (2016 - 2025)

Clorox has reported Gains from Investment Securities over the past 16 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $1.0 million for Q4 2025, up 110.0% from a year ago — trailing twelve months through Dec 2025 was $268.0 million (down 25.97% YoY), and the annual figure for FY2025 was $264.0 million, down 23.92%.
  • Gains from Investment Securities for Q4 2025 was $1.0 million at Clorox, up from -$2.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CLX hit a ceiling of $365.0 million in Q2 2024 and a floor of -$36.0 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was -$1.0 million (2022), compared with a mean of $39.4 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 427.27% in 2022 and later skyrocketed 9225.0% in 2024.
  • Clorox's Gains from Investment Securities stood at $11.0 million in 2021, then tumbled by 427.27% to -$36.0 million in 2022, then skyrocketed by 47.22% to -$19.0 million in 2023, then soared by 47.37% to -$10.0 million in 2024, then surged by 110.0% to $1.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were $1.0 million (Q4 2025), -$2.0 million (Q3 2025), and $263.0 million (Q2 2025) per Business Quant data.